. Merck’s Covid Pill Is Authorized for High-Risk Adults « JO LEE MAGAZINE

NY TIMES – The F.D.A. cleared the pill, developed by Merck and known as molnupiravir, for adults who are vulnerable to becoming severely ill from Covid and for whom alternative treatment options are “not accessible or clinically appropriate.” The agency’s decision reflects concerns that Merck’s pill is only modestly effective and carries possible safety risks, including for pregnant women. Merck’s treatment is expected to be available early next month. With the Omicron variant driving an onslaught of infections, the drug will be in greater supply in the coming weeks than other treatments in the United States.

Breaking News at NY TIMES

World on the Run | Jo Lee Magazine

Comments are closed.